SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.135
+0.085 (2.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $211.19 million as of April 25, 2025. Its market cap has decreased by -34.93% in one year.
Market Cap
211.19M
Enterprise Value
160.99M
1-Year Change
-34.93%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $211.19M, a decrease of -81.15%. That is a compound annual growth rate of -35.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 203.83M | -0.06% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 768.81B |
| UnitedHealth Group | 378.07B |
| Johnson & Johnson | 369.33B |
| AbbVie | 323.52B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.25B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |